Publications by authors named "Nancy Peacock"

Claim this Profile
A
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
Denise A Yardley, Robyn R Young, Kerin B Adelson, Andrea L Silber, Jose E Najera, Nancy Peacock

Clin Breast Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy.
Denise A Yardley, Nancy Peacock, Brooke Daniel, Betrand Anz, David C Molthrop

Breast Cancer Res Treat· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers.
Johanna C Bendell, Ahmed Zakari, Evan Lang, David Waterhouse, Douglas Flora, Nancy Peacock

Cancer Invest· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute.
Denise A Yardley, Linda D Bosserman, Joyce A O'Shaughnessy, William N Harwin, Susan K Morgan, Nancy W Peacock

Breast Cancer Res Treat· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score.
Denise A Yardley, Nancy W Peacock, Mythili Shastry, Howard A Burris, Rebecca G Bechhold

Breast Cancer Res Treat· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer.
Denise A Yardley, Dianna L Shipley, Nancy W Peacock, Mythili Shastry, Rajiv Midha

Breast Cancer Res Treat· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study.
James W Gilmore, Nancy W Peacock, Anna Gu, Stephen Szabo, Melissa Rammage

J Oncol Pract· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program.
Victoria S Blinder, Virginia W Norris, Nancy W Peacock, Jennifer J Griggs, David P Harrington

Cancer· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors.
Suzanne F Jones, Jeffrey R Infante, David R Spigel, Nancy W Peacock, Dana S Thompson

Cancer Invest· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer.
David R Spigel, John D Hainsworth, Howard A Burris, David C Molthrop, Nancy Peacock

Clin Adv Hematol Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer.
Denise Yardley, Howard Burris, Nancy Peacock, Eric Raefsky, Marianne Melnik

Breast Cancer Res Treat· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer.
Denise A Yardley, Nancy W Peacock, Natalie R Dickson, Melissa B White, Elizabeth R Vázquez

Clin Breast Cancer· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab.
David R Spigel, John D Hainsworth, Denise A Yardley, Eric Raefsky, Jeffrey Patton, Nancy Peacock

J Clin Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast cancer.
Anna Maria Storniolo, Mark D Pegram, Beth Overmoyer, Paula Silverman, Nancy W Peacock

J Clin Oncol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer.
Denise A Yardley, Howard A Burris, Cindy P Farley, John H Barton, Nancy W Peacock

Clin Breast Cancer· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis